Tristel lifts full year forecast
Contamination and infection control products maker Tristel said it expects full year profit to come in ahead of previous forecasts after a strong performance across all of the group's divisions in late June.
Contamination and infection control products maker Tristel said it expects full year profit to come in ahead of previous forecasts after a strong performance across all of the group's divisions in late June.
Results to 30 June 2012 will now show adjusted pre-tax profits in excess of £700,000. Last month the group said it expected to report an adjusted pre-tax profit of around £650,000.
It also achieved revenues ahead of the level previously indicated in its update on 15 June when it said it anticipated revenue of no less than £10.7m. This followed a strong performance both in the UK and overseas.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Chief executive Paul Swinney commented: "We are pleased with the progress we are making in establishing direct relationships with the three major national wholesalers who together represent the main distribution route into the UK veterinary market."
At its year-end the company had cash balances of £600,000.
Tristel said it expects to announce its preliminary results for the year to 30 June on 29 October 2012.
CJ
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Thousands of Brits switch to Nationwide, Monzo and HSBC – which banks are least popular?
As current account bank switches reach a record high, we look at the most and least popular banks and building societies among Brits. Is it worth switching?
-
Are these FTSE 100 pharmaceutical stocks worth a look?
Pharmaceutical stocks are some of the biggest in the FTSE 100. The sector is threatened by tariffs, but some have posted encouraging results regardless.